Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 85

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 85
---
 adjustment under the terms of the Fifth Amended Plan. Shares Available for Awards Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common stock that may be issued under the Fifth Amended Plan will not exceed 21,303,334 shares, which is the sum of (i) 36,667 shares approved at the Company’s 2020 annual meeting of stockholders, plus(ii) 66,667 shares approved at the Company’s 2021 annual meeting of stockholders, plus(iii) 133,333 shares approved at the Company’s 2022 annual meeting of stockholders, plus(iv) 66,667 shares approved at the Company’s 2023 annual meeting of stockholders, plus(v) 1,000,000 Shares approved at the Company’s 2024 annual meeting of stockholders, plus(vi) 20,000,000 Shares approved at the Company’s 2025 annual meeting of stockholders, plus(vii) the number of unallocated shares remaining available for grant under the Plus Therapeutics, Inc. 2014 Equity Incentive Plan, as amended (the “2014 Plan”) as of the effective date of the Plan, plus(viii) the Predecessor Plan’s Returning Shares (as defined below), as such shares become available from time to time. The term “Predecessor Plan’s Returning Shares” refers to the following shares of our Common Stock subject to any outstanding stock award granted under the 2014 Plan: (i) any shares subject to such stock award that are not issued because such stock award expired or otherwise terminated without all of the shares covered by such stock award having been issued, and (ii) any shares issued pursuant to such stock award that are forfeited back to us because of a failure to vest. The number of shares that may be delivered in the aggregate pursuant to the exercise of incentive stock options granted under the Fifth Amended Plan will not exceed 21,303,334 shares, to the extent allowable under Section 422 of the Code, any shares that become available for issuance under the Fifth Amended Plan discussed below as a result of forfeiture or termination of awards. These limitations, and the terms of outstanding awards, shall be adjusted as appropriate and equitable in the event of a stock dividend, stock split, reclassification of stock or similar events. If stock units, options, or stock appreciation rights are forfeited or terminate for any other reason before being settled or exercised, or if restricted shares are forfe